Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodolfo Montironi

Showing results (41-50 of 801) with videos related to

Pageof 81
Sort By:
European Urology|August 23, 2008
Editorial comment on: Prevalence of a tertiary Gleason grade and its impact on adverse histopathologic parameters in a contemporary radical prostatectomy seriesAntonio Lopez-Beltran, Rodolfo Montironi, Liang Cheng
Histopathology|December 11, 2013
Microcystic urothelial carcinoma: morphology, immunohistochemistry and clinical behaviourAntonio Lopez Beltran, Rodolfo Montironi, Liang Cheng
Virchows Archiv : an International Journal of Pathology|March 27, 2004
Carcinoma of the prostate: inherited susceptibility, somatic gene defects and androgen receptorsRodolfo Montironi, Marina Scarpelli, Antonio López Beltran
Current Drug Targets|March 28, 2020
PD1/PD-L1 Axis in Uro-oncologyKerstin Junker, Markus Eckstein, Michelangelo Fiorentino, et al.
Urologia Internationalis|April 16, 2004
Neoadjuvant hormone treatment with leuprolide acetate depot 3.75 mg and cyproterone acetate, before radical prostatectomy: a randomized studyDomenico Prezioso, Tullio Lotti, Mario Polito, et al.
Current Opinion in Urology|June 17, 2016
Contemporary Gleason grading and novel Grade Groups in clinical practiceCristina Magi-Galluzzi, Rodolfo Montironi, Jonathan I Epstein
Current Drug Targets|May 11, 2020
PD-L1 Testing for Urothelial Carcinoma: Interchangeability, Reliability and Future PerspectivesThomas Gevaert, Alessia Cimadamore, Rodolfo Montironi, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|May 1, 2021
Manipulating macrophage polarization in cancer patients: From nanoparticles to human chimeric antigen receptor macrophagesMatteo Santoni, Francesco Massari, Rodolfo Montironi, et al.
Advances in Experimental Medicine and Biology|June 29, 2021
Seminal Vesicle Tumor MicroenvironmentAlessia Cimadamore, Rodolfo Montironi, Sergio Serni, et al.
Analytical and Quantitative Cytology and Histology|April 28, 2006
Cyclin E as molecular marker in the management of breast cancer: a reviewAntonio Lopez-Beltran, Gregory T MacLennan, Rodolfo Montironi
Pageof 81

Showing results (41-50 of 801) with videos related to

Sort By:
Pageof 81
European Urology|August 23, 2008
Editorial comment on: Prevalence of a tertiary Gleason grade and its impact on adverse histopathologic parameters in a contemporary radical prostatectomy seriesAntonio Lopez-Beltran, Rodolfo Montironi, Liang Cheng
Histopathology|December 11, 2013
Microcystic urothelial carcinoma: morphology, immunohistochemistry and clinical behaviourAntonio Lopez Beltran, Rodolfo Montironi, Liang Cheng
Virchows Archiv : an International Journal of Pathology|March 27, 2004
Carcinoma of the prostate: inherited susceptibility, somatic gene defects and androgen receptorsRodolfo Montironi, Marina Scarpelli, Antonio López Beltran
Current Drug Targets|March 28, 2020
PD1/PD-L1 Axis in Uro-oncologyKerstin Junker, Markus Eckstein, Michelangelo Fiorentino, et al.
Urologia Internationalis|April 16, 2004
Neoadjuvant hormone treatment with leuprolide acetate depot 3.75 mg and cyproterone acetate, before radical prostatectomy: a randomized studyDomenico Prezioso, Tullio Lotti, Mario Polito, et al.
Current Opinion in Urology|June 17, 2016
Contemporary Gleason grading and novel Grade Groups in clinical practiceCristina Magi-Galluzzi, Rodolfo Montironi, Jonathan I Epstein
Current Drug Targets|May 11, 2020
PD-L1 Testing for Urothelial Carcinoma: Interchangeability, Reliability and Future PerspectivesThomas Gevaert, Alessia Cimadamore, Rodolfo Montironi, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|May 1, 2021
Manipulating macrophage polarization in cancer patients: From nanoparticles to human chimeric antigen receptor macrophagesMatteo Santoni, Francesco Massari, Rodolfo Montironi, et al.
Advances in Experimental Medicine and Biology|June 29, 2021
Seminal Vesicle Tumor MicroenvironmentAlessia Cimadamore, Rodolfo Montironi, Sergio Serni, et al.
Analytical and Quantitative Cytology and Histology|April 28, 2006
Cyclin E as molecular marker in the management of breast cancer: a reviewAntonio Lopez-Beltran, Gregory T MacLennan, Rodolfo Montironi
Pageof 81